Additional recent evidence indicates that ∼14% of cases of severe COVID-19 either have genetic flaws in IFN production or antibodies that attack IFN itself, leading to reduced serum IFN or an inability to produce IFN (2,39). The gene discussed is IFNA1; the disease is COVID-19.